Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion type Assertion NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_head.
- NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion description "[These studies are the first to demonstrate a prognostic role of B2M at the mRNA level and suggest that low B2M expression levels might be useful for identifying patients with lymph node metastasis and/or poor survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_provenance.
- NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion evidence source_evidence_literature NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_provenance.
- NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion SIO_000772 18506145 NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_provenance.
- NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion wasDerivedFrom befree-20140225 NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_provenance.
- NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_assertion wasGeneratedBy ECO_0000203 NP885728.RAe9WnRnAdTmfMePUXmLQ4H0WMU5ooMYJCPZPFgUucV90130_provenance.